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Abstract
Background: Recruitment to clinical trials can be challenging. We identified anonymous potential participants to an 
existing pragmatic randomised controlled depression trial to assess the feasibility of using routinely collected data to 
identify potential trial participants. We discuss the strengths and limitations of this approach, assess its potential value, 
report challenges and ethical issues encountered.
Methods: Swansea University's Health Information Research Unit's Secure Anonymised Information Linkage (SAIL) 
database of routinely collected health records was interrogated, using Structured Query Language (SQL). Read codes 
were used to create an algorithm of inclusion/exclusion criteria with which to identify suitable anonymous 
participants. Two independent clinicians rated the eligibility of the potential participants' identified. Inter-rater 
reliability was assessed using the kappa statistic and inter-class correlation.
Results: The study population (N = 37263) comprised all adults registered at five general practices in Swansea UK. 
Using the algorithm 867 anonymous potential participants were identified. The sensitivity and specificity results > 0.9 
suggested a high degree of accuracy from the algorithm. The inter-rater reliability results indicated strong agreement 
between the confirming raters. The Intra Class Correlation Coefficient (Cronbach's Alpha) > 0.9, suggested excellent 
agreement and Kappa coefficient > 0.8; almost perfect agreement.
Conclusions: This proof of concept study showed that routinely collected primary care data can be used to identify 
potential participants for a pragmatic randomised controlled trial of folate augmentation of antidepressant therapy for 
the treatment of depression. Further work will be needed to assess generalisability to other conditions and settings 
and the inclusion of this approach to support Electronic Enhanced Recruitment (EER).
Background
Recruitment to clinical trials in primary care can be chal-
lenging [1]. Recent papers in Trials have reported a vari-
ety of strategies to improve trial recruitment [2-4].
Drawing on the expanding field of health informatics, we
report on a strategy to identify potential trial participants
using routinely collected anonymised data that comple-
ments other approaches to this question [5]. Virtually all
general practices in the UK hold patient medical records
in electronic format. This level of computerisation is in
line with the NHS 1998 Information for Health Strategy's
goal of full implementation of person-based Electronic
Health Records (EHRs) at the primary care level by 2005.
Routinely collected data are recorded in both narrative
and structured formats. In the structured format, data are
presented in codes. The coding system adopted by the
Department of Health for general practice is the Read
Terminology [6], although plans are underway to migrate
to Systematised Nomenclature for Medicine - Clinical
Terms (SNOMED CT) [6]; which has been selected as the
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standard terminology scheme for the NHS Care Records
Service and for the National Programme for IT and will
eventually replace the current Clinical (Read) codes.
Large volumes of routinely collected data held in elec-
tronic format are becoming increasingly available.
Improvements in data quality as well as technological
advancement and expertise in retrieving, transporting,
storing, linking and analysing these data is leading to
Health Informatics emerging as a field rich with potential
for research purposes [7].
Most randomised studies in general practice use con-
ventional methods for patient selection, recruitment and
data collection. One conventional method is through
General Practitioner (GP) referral to research trials. Doc-
tors normally recruit when patients present themselves at
appointments. However a limitation with this method is
that no referral will be made for those patients who do
not attend their appointments, therefore little can be said
about the generalisability of the data. Other recruitment
strategies include manual searches through patient
records or database searches using diagnostic criteria to
select and recruit patients and then sending out partici-
pant information sheets. Further strategies include use of
multi-media, such as the internet [5], newsletters and also
mail shots. Further strategies include use of multi-media,
such as the internet, newsletters and also mail shots. All
searches for potential participants that involve disclosure
of identifiable information (without patients' consent) are
undertaken by the patients' direct healthcare team. How-
ever, if there is no other practicable alternative to con-
ducting the research an application can be made to the
National Information Governance Board (NIGB). NIGB
oversees applications for the common law duty of confi-
dentiality to be set aside in specific circumstances, in
accordance with Section 251 of the NHS Act [8].
Many trials in primary care fail to achieve satisfactory
levels of recruitment.
Difficulties with achieving the target recruitment popu-
lations within fixed timeframes were observed as com-
mon problems [9]. A number of barriers to clinician
participation have been identified including time con-
straints, lack of staff and training, and concern about the
impact on doctor-patient relationship [10,11]. In addi-
tion, barriers to GP referrals in depression trials have
included the unsuitability of the content and style of
depression consultations and the perceived intrusiveness
of introducing research into a complex consultation [12].
It seems that the demands on patients and clinicians need
to be kept to a minimum [10].
Routine data may overcome some of these issues. It
may eliminate the need for doctors to identify suitable
patients when they attend the practice. The significant
advantage is that larger numbers of suitable patients can
be identified by this method in a shorter period of time,
thus maximising recruitment and minimising costs.
However, it should be noted that routine data requires
validation, which needs to be factored into the resource
and economic planning.
The Health Information Research Unit (HIRU)[13]
based in the School of Medicine, Swansea University has
been formed to harness the potential of routinely col-
lected data. HIRU has established the Secure Ano-
nymised Information Linkage (SAIL) database, which is a
vast data repository of anonymised person-level data, as
provided by an expanding group of Data Providers [14].
In total so far, around 700 million records, pertaining to
Health and Social care events have been loaded into the
SAIL Data Bank. HIRU, in conjunction with Health Solu-
tion Wales, UK (HSW) have developed a robust ano-
nymisation system to ensure confidentiality whilst
making the data available for research [15,16].
The purpose of this study was to construct a methodol-
ogy for identifying potential participants for a trial using
the routinely collected data stored in the SAIL databank
and to determine if the methodology could correctly
identify potential participants for a clinical trial. The trial
identified for this project is the FolATED study, which is a
pragmatic randomised controlled trial of folate augmen-
tation of antidepressant therapy in the treatment of
depression. It is currently being conducted in Wales, UK
[17].
Aim
To determine whether anonymised routine data can be
used to accurately identify the numbers of eligible
patients suitable for recruitment to an existing ran-
domised controlled trial (RCT).
Objectives
• To construct an algorithm to identify suitable par-
ticipants for a clinical trial using routinely collected,
anonymised primary care data stored in the SAIL
databank.
• To carry out a validation exercise to establish




The FolATED RCT inclusion and exclusion criteria and
the timeframes for each criterion (see Tables 1 &2) were
used as the basis to determine whether appropriate
patients could be identified within the SAIL databank.
These clinical criteria were translated into codified con-
trolled measures (Read codes Version 2- [See Additional
File 1]. The NHS Read Terminology Version 2 (5-byte)
browser was used to identify appropriate read codes. To
ensure that all exclusion criteria had been taken into
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account, the new GP Contract Qualities and Outcomes
Framework (QOF) Version 10 Indicator Sets were used as
an additional tool to identify codes for depression, learn-
ing disability, psychoses, Lithium prescription, palliative
care and cancer. The British National Formulary (BNF)
Version 54 [18] was checked for criteria relating to drugs
and medicines, although all the relevant read codes were
identified from the NHS browser, both by generic and
brand names.
Inclusion and Exclusion Criteria
Inclusion and exclusion criteria are summarised in Table
3. From the five practises we included all persons aged 18
and over. We then used recent antidepressant therapy
(within last three months) as a proxy measure to identify
a large enough sample of people who were currently suf-
fering from depression. We then applied a diagnostic cri-
terion of a diagnosis of moderate to severe depression
within their medical history recorded on the SAIL data-
bank (1993-2007). This latter criterion was intended to
increase specificity and to reduce the possibility of cap-
turing patients who suffered from mild depression, senile
dementia with depression and other medical conditions.
Finally we applied the FolATED study exclusion criteria
to the algorithm in order to remove ineligible patients
from the sample. Scoring on any one of these criteria led
to exclusion.
Data analysis
A database query using the Structured Query Language
(SQL) was constructed using the identified read codes.
The algorithm was run against the General Practice Data-
base (GPD) within SAIL.
Validation
Two samples were identified, in order to check the valid-
ity of this methodology for selecting potential partici-
pants. A 10% random sample of the eligible patients were
chosen and a second sample of eighty ineligible patients
was selected from the main SAIL database. The two sam-
ples were combined to form one dataset. Two indepen-
dent mental health clinicians were given secure access to
the anonymised health records of these selected patients
and rated their eligibility for the trial. The sensitivity and
specificity of the method of routine data capture to select
eligible patients was calculated using clinical judgement
of diagnosis as the 'gold standard'.
Statistical analysis
Sensitivity and specificity tests were carried out to mea-
sure the reliability and accuracy of the results from the
validation exercise, comparing the algorithm decision
with the clinical judgement. Intra-class correlation coeffi-
cient and the kappa Statistic were carried out to measure
the agreement between the two clinicians. Statistical
analyses were performed using SPSS version 13 [19].
Data anonymisation
HIRU has a protocol in place with HSW to ensure that all
data is anonymised. This has been achieved through the
split file approach to data management. The demo-
graphic data is separated from the clinical data by the
source organisation and a system linking field is used to
ensure that the data can be rejoined later. The demo-
graphic data is sent to HSW and the clinical data is sent
to HIRU. HSW use encryption technology for pseud-
onymisation, replacing the personal data in each record
with an Anonymous Linking Field (ALF). This product is
then transferred to HIRU where it is joined to the clinical
data via the system linking field. As a final safeguard
HIRU further encrypts the ALF, thus ensuring that no
single organisation can decrypt the records. This split file
method ensures that anonymity and confidentiality is
maintained, whilst maintaining the facility of data linkage
Table 1: Results of applying inclusion and exclusion criteria 
to identify potential trial participants from five general 
practices
Criterion applied Potential participants
remaining
Aged 18 years and over 37263
Antidepressant therapy within last 3 
months
2650
Lifetime diagnosis of moderate to 
severe depression
1247
Folate deficient <2.5 ng/L at any time 1237
B12 deficient <150 pg/ml at any time 1196
Taking folic acid supplements in last 2 
months
1180
Lifetime diagnosis of psychosis 1116
Pregnant or planning pregnancy in last 
10 months
1116
Taking anticonvulsants at any time 1008
Life expectancy less than 1 year 1007
Any unstable medical condition in last 
12 months
976
Taking Lithium at any time 965
Lifetime diagnosis of malignancy 873
Adverse reaction to folic acid a any time 873
Depression resolved in last 3 months 872
Lifetime diagnosis of delirium 871
Lifetime diagnosis of learning disability 867
Final number of potential trial 
participants
867
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at the individual level. The data is then ready for research
applications [16]. Only the source organisation (i.e. the
treating physician) has access to both personal and clini-
cal data. The data is provided to the SAIL database on the
grounds that it is never deanonymised, patient records
can never be traced back to individual patients.
Ethics
The work of the SAIL databank is conducted in strict
accordance with a suite of data management policies
which take account of the Data Protection Act (1998)[20],
the Principles of the Caldicott report (1997)[21] and
other measures that embody good practice in informa-
tion governance. The information principles underpin-
ning the work of SAIL have been endorsed by Informing
Healthcare [22] and the Corporate Health Information
Programme (CHIP)[23] and have been reviewed by Cal-
dicott Guardians and Information Governance Officers
in the NHS and Local Government. At a project level, all
proposals for data utilisation are scrutinized for compli-
ance with information governance by an independent
panel comprised of members from: the British Medical
Association, Informing Healthcare, Public Health Wales
NHS Trust, Involving People and the Multi-centre
Research Ethics Committee for Wales [14].
The FolATED study has been approved by the Multi-
centre Research Ethics Committee for Wales and by three
Local Research Ethics Committees (North East Wales,
North West Wales and Swansea Research).
Results
Identifying potential participants in SAIL
The practice data on the SAIL databank at the time of
analysis included data up to 31/8/07. From the sample
population of 37,263 patients aged 18 and over 2650 were
identified as having been prescribed antidepressants
within the last three months (7.11%). Of these 2650
patients 1247 had a diagnosis of moderate to severe
depression within their medical history recorded on the
SAIL databank (since ~1993). After application of all the
inclusion and exclusion criteria 867 potential trial partici-
pants for the FolATED study were identified (Table 1).
Validation
88 cases identified using the algorithm and 80 randomly
selected individuals who did not meet the inclusion crite-
ria were selected from the SAIL data bank. The accuracy
of the algorithm was compared against the judgment of
two psychiatrists (PC) and (JC) who independently rated
all 168 records for evidence of a diagnosis of current
depression. Table 2 shows the sensitivity and specificity
of the algorithm against the clinical gold standard.
The two raters' independent classification of cases had
an intra-Class Correlation Coefficient ICC (Cronbach's
Alpha) of 0.93; (excellent agreement >= 0.9)[24,25] and a
Cohen's Kappa Coefficient of 0.87; (almost perfect agree-
ment >= 0.8) [24,25].
Discussion
The algorithm for identifying suitable participants for the
FolATED study appears to be valid based on the clinical
judgment of the raters. The results from the sensitivity
and specificity suggested a high degree of accuracy (>=
80%) from the algorithm. Although some minor method-
ological issues were encountered, we have demonstrated
that it is possible to identify anonymous potential trial
participants using the routinely collected primary care
data.
Limitations of the proposed method
A system based on anonymised data cannot be applied
directly to recruitment strategies, as for instance the data
housed in SAIL can never be deanonymised.
So this method we are exploring is a two part process.
Firstly creating, testing and validating an algorithm to
identify suitable participants using the anonymised data
in SAIL. Then making this algorithm available on a live
practice based computer based facility (such as Audit+
[26]) whereby a physician can run the query themselves
and generate a list of suitable named participants within
the practice, with minimal time or effort. Thus this
should reduce GPs workload, with the potential of maxi-
mising recruitment. The method ensures confidentiality
of personal data as the identification and recruitment
process remains within the practices. This process itself
requires validation. Furthermore, missing or implausible
data values in the electronic records cannot be corrected
as it is not possible to identify the patient.
Additionally, there was also an additional requirement
for the researcher to seek clinical expertise to identify
Table 2: Detection by algorithm of potential trial 
participants compared to detection by two independent 
clinicians.
Test characteristic Clinician 1 Clinician 2
True Positives 87 81
False negatives 1 7
False Positives 0 3




Positive predictive value 0.96 1.0
Negative predictive value 0.92 0.99
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appropriate read codes. For example, medical advice was
sought as to whether to include read codes relating to
post viral depression and pre-senile dementia with
depression in the algorithm.
Limitations of routinely collected data
There are also a number of general limitations to the use
of routinely collected data. The accuracy of using proxy
measures needs to be evaluated. Lack of linkage between
diagnosis and therapy makes the use of proxy measures
unreliable. This issue is not limited to this methodology
but applies to live database searches too. In this study
recent antidepressant therapy was used as a proxy mea-
sure for depression to try to capture patients who were
currently depressed, as the diagnosis may not be recorded
as frequently as the treatment prescribed if it is an ongo-
ing condition. The use of antidepressants as a proxy mea-
sure for depression is unreliable because disorders cannot
be linked to specific interventions i.e. drugs [27]. An
attempt to counter this was made by selecting people who
had a diagnosis of moderate to severe depression in their
medical history, however there was no way of knowing
whether their current antidepressant therapy was related
to that diagnosis. Antidepressant therapy may have been
prescribed for other conditions, such as anxiety disor-
ders, attention deficit disorder or dementia. It would be
useful if there was a standardised 'problem number' field
in all primary care data entry systems that linked the pre-
scription to the diagnosis. The Meditel system has this
field [28].
A particular challenge is establishing the end date of an
episode of depression and whether or not the patient is in
remission. The codes that might assist in identifying this,
such as depression resolved, medication stopped and
medication changed, may be infrequently employed and
therefore cannot be relied upon as accurate measures in
themselves.
Routinely collected data are captured for administrative
reasons rather than for research purposes. To be fit for
research purposes the validity, accuracy and complete-
ness of the routine data itself need to be considered.
Although studies have reported that routinely collected
diagnostic data held on general practice information sys-
tems are accurate and reliable for research purposes [29-
31], there is always room for initiatives to standardise sys-
tems and to improve data quality in primary care [32].
The purpose of this study was to model using ano-
nymised data a new method of identifying suitable partic-
ipants using routinely collected data that would make it
easier for practices to identify potential subjects for a
clinical trial and consequently reduce their workload,
whilst potentially maximising recruitment and reducing
costs. In the future we will seek to test this algorithm on
clinical data sets within primary care settings. The algo-
rithm that was created in this study successfully identi-
fied suitable anonymous participants for the trial within
the SAIL environment. However the data within SAIL
can never be deanonymised. Therefore the next phase is a
pilot project for the translation of the algorithm running
on anonymised SAIL data to run on live clinical systems,
where the individual physician can generate a list of
potential identifiable participants, with minimal time and
effort. The method ensures confidentiality of personal
data as the identification and recruitment process
remains within the practices.
Conclusions
The use of routinely collected digitally stored clinical data
from primary care can be used as a means of selecting
anonymous possible participants for a trial of folate aug-
mentation of antidepressant therapy. Future work is
required to run this algorithm on patient identifiable sys-
tems within the primary care practice setting and then
compare this method with the traditional non-electronic
method of participant identification for recruitment, in
terms of numbers recruited, time, cost and reliability.
Table 3: Trial inclusion and exclusion criteria used to search 
patient database
Inclusion criteria Time Frame
Aged 18 years and over At any time
And Antidepressant therapy Within last 3 months
And Diagnosis of moderate to severe 
depression
At any time
Patients excluded on basis of any one of
Folate deficient <2.5 ng/L At any time
B12 deficient <150 pg/ml At any time
Taking folic acid supplements Within last two months
Past diagnosis of psychosis At any time
Pregnant or planning pregnancy Within last 10 months
Taking anticonvulsants At any time
Life expectancy less than 1 year At any time
Any unstable medical condition Within last 12 months
Taking Lithium At any time
Any malignancy At any time
Adverse reaction to folic acid At any time
Depression resolved Within last three 
months
Delirium At any time
Learning disability At any time
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